Sun Lixiao, Fu Yuxin, Yang Jiecheng, Wang Xiaoli, Cui Dongsheng, Feng Qiang, Song Xuguang, Li Zhe, Wang Zhuangwei, Wang Wenchao, Wu Yiping, Wang Jingmei
Department of Critical Care Medicine, Handan Central Hospital, Handan, China.
Child Care, Merice Cody Public School, Toronto, ON, Canada.
Front Neurol. 2025 Jul 10;16:1559688. doi: 10.3389/fneur.2025.1559688. eCollection 2025.
Prokineticin 2 is associated with the macrophages-mediated biological process, neuronal death, oxidative stress, and inflammatory processes, while its clinical value in patients with acute ischemic stroke (AIS) has not been explored. This study aimed to evaluate the level of prokineticin 2 and its association with inflammatory indexes and functional recovery in AIS patients.
Serum samples in 210 AIS patients at admission and in 30 healthy subjects at enrollment were collected. Then, prokineticin 2 levels were determined by enzyme-linked immunosorbent assay.
Prokineticin 2 level was higher in AIS patients than healthy subjects ( < 0.001). Prokineticin 2 showed an acceptable ability to distinguish the AIS patients from healthy subjects (area under the curve: 0.812) with the best cut-off value at 4 ng/mL. No matter dividing the prokineticin 2 by continuous variable or quartiles, its value was positively correlated with the high sensitivity C reactive protein (HsCRP), tumor necrosis factor-alpha (TNF-), and interleukin 17A (IL-17A) (all < 0.001). Prokineticin 2 showed a higher trend in AIS patients with Modified Rankin Scale (mRS) score>2 compared with those with mRS score ≤2, but without statistical significance ( = 0.095). Besides, there was no association between prokineticin 2 by quartiles and the percentage of mRS > 2 ( > 0.05).
Prokineticin 2 aberrantly highly expresses, and it indicates the inflammatory status, but with limited ability to predict the neural functional recovery in AIS patients.
促动力蛋白2与巨噬细胞介导的生物学过程、神经元死亡、氧化应激和炎症过程相关,但其在急性缺血性卒中(AIS)患者中的临床价值尚未得到探索。本研究旨在评估AIS患者促动力蛋白2水平及其与炎症指标和功能恢复的关系。
收集210例AIS患者入院时的血清样本和30例健康受试者入组时的血清样本。然后,采用酶联免疫吸附测定法测定促动力蛋白2水平。
AIS患者促动力蛋白2水平高于健康受试者(<0.001)。促动力蛋白2在区分AIS患者与健康受试者方面具有可接受的能力(曲线下面积:0.812),最佳截断值为4 ng/mL。无论将促动力蛋白2按连续变量还是四分位数划分,其值均与高敏C反应蛋白(HsCRP)、肿瘤坏死因子-α(TNF-)和白细胞介素17A(IL-17A)呈正相关(均<0.001)。与改良Rankin量表(mRS)评分≤2的AIS患者相比,mRS评分>2的AIS患者促动力蛋白2呈升高趋势,但无统计学意义(=0.095)。此外,按四分位数划分的促动力蛋白2与mRS>2的百分比之间无关联(>0.05)。
促动力蛋白2异常高表达,提示炎症状态,但预测AIS患者神经功能恢复的能力有限。